IonQ(US:IONQ) ZACKS·2026-01-05 13:30Core Insights - IonQ is expanding its strategic partnerships in healthcare, logistics, and academia to promote the adoption of quantum computing in real-world applications [2][3][4][8] Healthcare Partnerships - IonQ has partnered with the Centre for Commercialization of Regenerative Medicine (CCRM) to develop next-generation therapeutics using hybrid quantum and quantum-AI technologies, with initial projects set to launch in Canada and Sweden in 2026 [2][8] Logistics Partnerships - IonQ has formed an investment partnership with Einride, a global leader in digital, electric, and autonomous logistics solutions, aiming to enhance efficiency, reliability, and sustainability in the freight industry through the integration of quantum systems [3][8] Academic Collaborations - A strategic agreement with the University of Chicago will establish the IonQ Center for Engineering and Science, where a next-generation quantum computer and an entanglement distribution quantum network will be deployed to support research and generate intellectual property [4][8] Industry Updates - Quantum Computing Inc. (QUBT) and POET Technologies Inc. (POET) are collaborating to develop high-performance 400G/Lane modulators, which will significantly increase networking speeds [5] - D-Wave Quantum Inc. (QBTS) and BASF have completed a proof-of-concept project that optimized manufacturing workflows, reducing production scheduling time from 10 hours to seconds [6] Stock Performance - Year-to-date, IonQ's shares have increased by 4.2%, slightly underperforming the industry growth of 4.5% [7] - IonQ's current forward Price-to-Sales (P/S) ratio is 81.07X, significantly higher than the industry average of 3.70X, indicating an expensive valuation [10] Earnings Estimates - In the past 30 days, IonQ's loss per share estimate for 2025 has narrowed by 6 cents [12] - Current estimates for the upcoming quarters show a loss per share of -0.48 for the current quarter and -0.47 for the next quarter [13]